LP14719-6glipiZIDEActive
Descriptions
LP14719-6 glipiZIDE
An oral hypoglycemic agent which is rapidly absorbed and completely metabolized.
Source: National Library of Medicine, MeSH 2006
LP14719-6 glipiZIDE
Sulfonylurea (UK: Sulphonylurea) derivatives are antidiabetic drugs primarily used to treat diabetes mellitus type 2, and include drugs such as Chlorpropamide, Tolazamide, Tolbutamide, Glyburide, Gliclazide, Glipizide, Gliquidone, Acetohexamide and others. They act by increasing insulin release from the beta cells in the pancreas. Sulfonylureas are ineffective where there is absolute deficiency of insulin production such as in type 1 diabetes or post-pancreatectomy.
Copyright Text is available under the Creative Commons Attribution/Share-Alike License. See http://creativecommons.org/licenses/by-sa/3.0/ for details.
Source: Wikipedia, Sulfonylureas
Basic Part Properties
- Name
- glipiZIDE
- Type
- Component
- Created On
- 2000-05-04
- Construct for LOINC Short Name
- glipiZIDE
LOINC FHIR® API Example - CodeSystem Request Get Info
https://fhir.loinc.org/CodeSystem/$lookup?system=http://loinc.org&code=LP14719-6
Language Variants Get Info
- zh-CNChinese (China)
- 格列甲嗪
- nl-NLDutch (Netherlands)
- glipizide
- et-EEEstonian (Estonia)
- Glipisiid
- fr-BEFrench (Belgium)
- Glipizide
- fr-CAFrench (Canada)
- Glipizide
- it-ITItalian (Italy)
- Glipizide
- ru-RURussian (Russian Federation)
- Глипизид
- es-ESSpanish (Spain)
- Glipizida
- tr-TRTurkish (Turkey)
- Glipizid
LOINC Copyright
Copyright © 2022 Regenstrief Institute, Inc. All Rights Reserved. To the extent included herein, the LOINC table and LOINC codes are copyright